Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SAVA Cassava Sciences Inc

交易中 02-13 12:21:37 EST

2.15

+0.10

+4.63%

最高2.15	最低2.06	成交量21.40万
今开2.06	昨收2.05	日振幅4.15%
总市值1.04亿	流通市值9,325万	总股本4,831万
成交额44.92万	换手率0.49%	流通股本4,348万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SAVA","market":"US","secType":"STK","nameCN":"Cassava Sciences Inc","latestPrice":2.145,"timestamp":1771003296002,"preClose":2.05,"halted":0,"volume":213973,"delay":0,"changeRate":0.04634146341463424,"floatShares":43475193,"shares":48307896,"eps":-2.197613,"marketStatus":"交易中","change":0.095,"latestTime":"02-13 12:21:37 EST","open":2.06,"high":2.145,"low":2.06,"amount":449174.7748652,"amplitude":0.041463,"askPrice":2.15,"askSize":100,"bidPrice":2.14,"bidSize":1772,"shortable":3,"etf":0,"ttmEps":-2.197613,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771016400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.05,"preHourTrading":{"tag":"盘前","latestPrice":2.041,"preClose":2.05,"latestTime":"09:22 EST","volume":1007,"amount":2055.0888224,"timestamp":1770992538264,"change":-0.009,"changeRate":-0.00439,"amplitude":0.027463},"postHourTrading":{"tag":"盘后","latestPrice":2.09,"preClose":2.05,"latestTime":"19:37 EST","volume":8049,"amount":16693.7721,"timestamp":1770943027268,"change":0.04,"changeRate":0.019512,"amplitude":0.028976},"volumeRatio":0.800546,"impliedVol":1.4379,"impliedVolPercentile":0.8765},"requestUrl":"/m/hq/s/SAVA/tweets","defaultTab":"tweets","newsList":[{"id":"2605010410","title":"木薯科学盘中异动 快速上涨5.53%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605010410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605010410?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:55","pubTimestamp":1769093728,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日22时55分，木薯科学股票出现异动，股价大幅上涨5.53%。截至发稿，该股报2.29美元/股，成交量20.1374万股，换手率0.42%，振幅3.23%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。木薯科学股票所在的生物技术行业中，整体涨幅为0.66%。目前，该公司正在对阿尔茨海默氏症痴呆患者进行两项口服simufilam的随机安慰剂对照 3 期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122225530953defb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122225530953defb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","SAVA","BK4547","BK4588"],"gpt_icon":0},{"id":"2604923156","title":"木薯科学盘中异动 临近收盘大幅跳水5.07%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923156?lang=zh_cn&edition=full","pubTime":"2026-01-17 04:39","pubTimestamp":1768595990,"startTime":"0","endTime":"0","summary":"北京时间2026年01月17日04时39分，木薯科学股票出现异动，股价快速下跌5.07%。截至发稿，该股报2.02美元/股，成交量95.1485万股，换手率1.97%，振幅6.10%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。木薯科学股票所在的生物技术行业中，整体跌幅为0.20%。目前，该公司正在对阿尔茨海默氏症痴呆患者进行两项口服simufilam的随机安慰剂对照 3 期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117043950953d1d43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117043950953d1d43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","SAVA","BK4585","BK4547","BK4007"],"gpt_icon":0},{"id":"1133689442","title":"Cassava Sciences：预计在2026年上半年不会启动Simufilam在TSC相关癫痫中的概念验证临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1133689442","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133689442?lang=zh_cn&edition=full","pubTime":"2025-12-19 06:08","pubTimestamp":1766095690,"startTime":"0","endTime":"0","summary":"Cassava Sciences：预计在2026年上半年不会启动Simufilam在TSC相关癫痫中的概念验证临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4007","BK4547","SAVA"],"gpt_icon":0},{"id":"1145500889","title":"Cassava Sciences Inc - FDA要求Cassava提供更多临床研究信息 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1145500889","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145500889?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:29","pubTimestamp":1764761351,"startTime":"0","endTime":"0","summary":"Cassava Sciences Inc - FDA要求Cassava提供更多临床研究信息 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA","BK4547","BK4588","BK4007","BK4585"],"gpt_icon":0},{"id":"2588948084","title":"木薯科学盘中异动 大幅跳水5.08%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588948084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588948084?lang=zh_cn&edition=full","pubTime":"2025-12-02 01:19","pubTimestamp":1764609592,"startTime":"0","endTime":"0","summary":"北京时间2025年12月02日01时19分，木薯科学股票出现异动，股价快速跳水5.08%。截至发稿，该股报3.09美元/股，成交量41.9866万股，换手率0.87%，振幅4.31%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。木薯科学股票所在的生物技术行业中，整体跌幅为1.58%。目前，该公司正在对阿尔茨海默氏症痴呆患者进行两项口服simufilam的随机安慰剂对照 3 期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202011952952510f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202011952952510f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA","BK4588","BK4585","BK4547","BK4007"],"gpt_icon":0},{"id":"2575414797","title":"木薯科学盘中异动 急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575414797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575414797?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:38","pubTimestamp":1760535489,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日21时38分，木薯科学股票出现波动，股价快速拉升5.19%。截至发稿，该股报4.66美元/股，成交量20.8306万股，换手率0.43%，振幅3.61%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。木薯科学股票所在的生物技术行业中，整体跌幅为0.17%。木薯科学公司简介：Cassava Sciences Inc是一家临床阶段的生物技术公司，致力于开发治疗和检测阿尔茨海默病的科学方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101521380994caf7b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101521380994caf7b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","SAVA","BK4547","BK4588"],"gpt_icon":0},{"id":"2574211194","title":"木薯科学盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574211194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574211194?lang=zh_cn&edition=full","pubTime":"2025-10-10 00:05","pubTimestamp":1760025919,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日00时05分，木薯科学股票出现异动，股价急速上涨5.03%。截至发稿，该股报4.18美元/股，成交量261.012万股，换手率5.40%，振幅6.41%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。木薯科学股票所在的生物技术行业中，整体跌幅为0.09%。目前，该公司正在对阿尔茨海默氏症痴呆患者进行两项口服simufilam的随机安慰剂对照 3 期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101000051994c0b42e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101000051994c0b42e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4547","SAVA","BK4585","BK4588"],"gpt_icon":0},{"id":"2570056475","title":"木薯科学盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570056475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570056475?lang=zh_cn&edition=full","pubTime":"2025-09-24 22:00","pubTimestamp":1758722446,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日22时00分，木薯科学股票出现异动，股价急速上涨5.01%。截至发稿，该股报3.58美元/股，成交量266.259万股，换手率5.51%，振幅9.68%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。木薯科学股票所在的生物技术行业中，整体跌幅为0.15%。木薯科学公司简介：Cassava Sciences Inc是一家临床阶段的生物技术公司，致力于开发治疗和检测阿尔茨海默病的科学方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092422004797a72b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092422004797a72b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SAVA","BK4588","BK4547","BK4585"],"gpt_icon":1},{"id":"2518275626","title":"木薯科学盘中异动 早盘股价大跌5.02%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275626?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:34","pubTimestamp":1741617275,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时34分，木薯科学股票出现波动，股价快速跳水5.02%。截至发稿，该股报2.67美元/股，成交量20.5909万股，换手率0.43%，振幅4.99%。木薯科学股票所在的生物技术行业中，整体涨幅为0.03%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223435a26a3cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223435a26a3cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SAVA","BK4588","BK4547","BK4585"],"gpt_icon":0},{"id":"2518423810","title":"木薯科学2024财年实现净利润-24.34百万美元，同比增加74.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518423810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518423810?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449675,"startTime":"0","endTime":"0","summary":"3月9日，木薯科学公布财报，公告显示公司2024财年净利润为-24.34百万美元，同比增加74.96%；其中营业收入为0.00美元，每股基本收益为-0.53美元。从资产负债表来看，木薯科学总负债11.83百万美元，其中短期债务0.00美元，资产负债比为0.14，流动比率为0.12。机构评级：截至2025年3月9日，当前有1家机构对木薯科学目标价做出预测，其中目标均价为2.00美元，其中最低目标价为2.00美元，最高目标价为2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000246abef988b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000246abef988b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA"],"gpt_icon":0},{"id":"2517598566","title":"木薯科学盘中异动 急速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517598566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517598566?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:06","pubTimestamp":1741118778,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时06分，木薯科学股票出现异动，股价急速上涨5.24%。截至发稿，该股报2.61美元/股，成交量104.366万股，换手率2.16%，振幅9.36%。木薯科学股票所在的生物技术行业中，整体涨幅为0.04%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040619abe84df8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305040619abe84df8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","SAVA","BK4547","BK4585","BK4007"],"gpt_icon":0},{"id":"2516323566","title":"木薯科学盘中异动 早盘急速上涨5.00%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516323566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516323566?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:34","pubTimestamp":1741012463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分，木薯科学股票出现波动，股价大幅拉升5.00%。截至发稿，该股报2.52美元/股，成交量8.4571万股，换手率0.18%，振幅4.17%。木薯科学股票所在的生物技术行业中，整体涨幅为0.38%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032234249637acf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032234249637acf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4547","SAVA","BK4007","BK4588"],"gpt_icon":0},{"id":"1126894554","title":"Cassava Sciences 2024 年第四季度 GAAP 每股亏损 $0.57 优于预期的 $0.66，现金及现金等价物为 $128.6M","url":"https://stock-news.laohu8.com/highlight/detail?id=1126894554","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126894554?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:38","pubTimestamp":1741005521,"startTime":"0","endTime":"0","summary":"Cassava Sciences  报告称季度每股亏损为 $0.57，优于分析师预期的每股亏损 $0.66，超出 13.64%。与去年同期每股亏损 $0.50 相比，这是 14% 的下降。以上内容来自Benzinga Earnings专栏，原文如下：Cassava Sciences  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 13.64 percent. This is a 14 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cassava Sciences 2024 年第四季度 GAAP 每股亏损 $0.57 优于预期的 $0.66，现金及现金等价物为 $128.6M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVA"],"gpt_icon":0},{"id":"2514501378","title":"木薯科学盘中异动 股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514501378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514501378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:41","pubTimestamp":1740753716,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时41分，木薯科学股票出现异动，股价急速下挫5.69%。截至发稿，该股报2.45美元/股，成交量18.4219万股，换手率0.38%，振幅2.69%。木薯科学股票所在的生物技术行业中，整体涨幅为0.33%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224156abe0ed99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224156abe0ed99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","SAVA","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"2514838592","title":"木薯科学盘中异动 股价大涨5.65%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514838592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514838592?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666745,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，木薯科学股票出现波动，股价急速拉升5.65%。截至发稿，该股报2.43美元/股，成交量19.7307万股，换手率0.41%，振幅3.91%。木薯科学股票所在的生物技术行业中，整体涨幅为0.31%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223225abdf6edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223225abdf6edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA","BK4547","BK4588","BK4007","BK4585"],"gpt_icon":0},{"id":"2514862748","title":"木薯科学盘中异动 股价大跌5.37%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862748?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:30","pubTimestamp":1740601805,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时30分，木薯科学股票出现异动，股价快速下跌5.37%。截至发稿，该股报2.29美元/股，成交量77.8881万股，换手率1.62%，振幅7.23%。木薯科学股票所在的生物技术行业中，整体跌幅为0.75%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227043005a25545fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227043005a25545fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","SAVA","BK4588","BK4007","BK4585"],"gpt_icon":0},{"id":"2514142470","title":"木薯科学盘中异动 急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514142470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514142470?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:31","pubTimestamp":1740501073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时31分，木薯科学股票出现波动，股价快速下挫5.20%。截至发稿，该股报2.37美元/股，成交量56.1182万股，换手率1.17%，振幅5.40%。木薯科学股票所在的生物技术行业中，整体涨幅为0.24%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003113a253a22b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003113a253a22b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","SAVA","BK4585","BK4547"],"gpt_icon":0},{"id":"2513214071","title":"木薯科学盘中异动 下午盘快速下跌5.00%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513214071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513214071?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:21","pubTimestamp":1740169296,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时21分，木薯科学股票出现异动，股价大幅下挫5.00%。截至发稿，该股报2.57美元/股，成交量87.099万股，换手率1.81%，振幅8.52%。木薯科学股票所在的生物技术行业中，整体涨幅为0.27%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222042137962bc4e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222042137962bc4e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAVA","BK4007","BK4547","BK4588","BK4585"],"gpt_icon":0},{"id":"2512484857","title":"木薯科学盘中异动 早盘急速拉升5.25%报2.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512484857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512484857?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:08","pubTimestamp":1739981317,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时08分，木薯科学股票出现异动，股价大幅上涨5.25%。截至发稿，该股报2.71美元/股，成交量61.2544万股，换手率1.27%，振幅6.94%。木薯科学股票所在的生物技术行业中，整体涨幅为0.45%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000837988b40d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000837988b40d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","SAVA","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"2512165478","title":"木薯科学盘中异动 早盘大幅上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165478?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:46","pubTimestamp":1739889962,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时46分，木薯科学股票出现异动，股价大幅上涨5.37%。截至发稿，该股报2.55美元/股，成交量24.0967万股，换手率0.50%，振幅3.31%。木薯科学股票所在的生物技术行业中，整体涨幅为0.88%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822460396279a82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822460396279a82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4585","BK4588","SAVA","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cassavasciences.com","stockEarnings":[{"period":"1week","weight":0.0847},{"period":"1month","weight":0},{"period":"3month","weight":-0.2572},{"period":"6month","weight":-0.1239},{"period":"1year","weight":-0.1202},{"period":"ytd","weight":0.0354}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cassava Sciences, Inc.是一家致力于开发新药的生物制药企业。公司主要候选药物称为羟考酮 (oxycodone) 缓释胶囊 。羟考酮是功效强大的止痛药，其独特的配方有助于减少非计划用量的潜在威胁。羟考酮和其他三种非滥用止疼药是按照与国王制药股份有限公司（King Pharmaceuticals, Inc.）的合作以及许可证协议（Pfizer Agreements）开发研制的。国王制药股份有限公司是辉瑞制药股份有限公司（Pfizer, Inc.）的子公司。公司于1998年5月在特拉华州注册成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.576923,"avgChangeRate":0.143985},{"month":2,"riseRate":0.461538,"avgChangeRate":0.027512},{"month":3,"riseRate":0.44,"avgChangeRate":0.008402},{"month":4,"riseRate":0.6,"avgChangeRate":0.05975},{"month":5,"riseRate":0.44,"avgChangeRate":0.038503},{"month":6,"riseRate":0.44,"avgChangeRate":-0.019669},{"month":7,"riseRate":0.48,"avgChangeRate":0.007146},{"month":8,"riseRate":0.5,"avgChangeRate":0.01628},{"month":9,"riseRate":0.615385,"avgChangeRate":0.114687},{"month":10,"riseRate":0.423077,"avgChangeRate":-0.039373},{"month":11,"riseRate":0.576923,"avgChangeRate":-0.009282},{"month":12,"riseRate":0.346154,"avgChangeRate":0.016148}],"exchange":"NASDAQ","name":"Cassava Sciences Inc","nameEN":"Cassava Sciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cassava Sciences Inc,SAVA,Cassava Sciences Inc股票,Cassava Sciences Inc股票老虎,Cassava Sciences Inc股票老虎国际,Cassava Sciences Inc行情,Cassava Sciences Inc股票行情,Cassava Sciences Inc股价,Cassava Sciences Inc股市,Cassava Sciences Inc股票价格,Cassava Sciences Inc股票交易,Cassava Sciences Inc股票购买,Cassava Sciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cassava Sciences Inc(SAVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cassava Sciences Inc(SAVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}